Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Encinitas, Califfornia--(Newsfile Corp. - August 7, 2026) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today reported financial results for the second quarter ended June 30, 2026, and provided an update on its clinical pipeline of small-molecule therapies for retinal diseases and its corporate development activities.Second Quarter 2026 and Recent HighlightsAdvanced enrollment in the Phase 2 ABACUS-2 clinical trial of KIO-301 into the higher-dose cohortContinued enrollment in the higher-dose...
Forfait Gratuit · Plus 29 $ CA ou Pro 99 $ CA/mois


